Zacks Adds Albemarle, American Airlines, and Aquestive Therapeutics to Strong Sell List

Zacks Investment Research··Read original
2▲0 ▼3Impact / 5
Summary · why it matters

Zacks Investment Research added three stocks to its Zacks Rank #5 (Strong Sell) list today. Albemarle, a specialty chemicals company, saw its current-year earnings consensus estimate revised 29.1% downward over the last 60 days. American Airlines, a network air carrier, had its estimate cut by 22.1%. Aquestive Therapeutics, a specialty pharmaceutical company, experienced a nearly 16.7% downward revision.

Impact on assets 6

Biotech & Genomic Medicine▼
Industrials▼
American Airlines Group
AAL
▼ NegativeCapitalrelevance

Earnings consensus estimate cut by 22.1% over 60 days, leading to Strong Sell rating.

Electrification & Mobility▼
Albemarle Corp
ALB
▼ NegativeCapitalrelevance

Earnings consensus estimate cut by 29.1% over 60 days, leading to Strong Sell rating.

Health Care▲
Energy Transition & Power Demand▲